1.
Activity of Belinostat in patients with recurrent or refractory peripheral or cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2025 Jun. 20];3(1). Available from: https://journals.pagepress.org/hmr/article/view/527